JUL 23, 2020 7:36 AM PDT

Cancer Therapy Reduces Lung Scarring

WRITTEN BY: Tara Fernandez

Scientists at the Stanford Institute for Stem Cell Biology and Regenerative Medicine have discovered a striking parallel between scar tissue formation and tumor growth: they both evade immune surveillance. As a result of this similarity, therapies to reactivate the immune system to target cancer cells have been shown to also work for treating scar tissue in the lung. The work was published recently in Nature Communications.

Idiopathic lung fibrosis is caused by overactive scar tissue cells called fibroblasts. Though the precise triggers and accelerants of fibrosis progression are still not fully understood, what is known is that in general, lung scarring is bad news. Progression of the conditions greatly limits the patients’ ability to breathe normally, with devastating effects on their overall quality of life. The only clinical intervention for advanced-stage lung fibrosis is a lung transplant.

The study, led by pathology expert Gerlinde Wernig, MD, aimed to identify how the normal molecular pathways involved in preventing overactive fibroblasts are disrupted in the case of fibrosis. Why don’t circulating immune cells such as macrophages detect a problem?

“In idiopathic lung disease, these fibroblasts behave almost like cancer cells,” said Wernig. 

“They grow over normal lung structures, obliterating airways, and blocking the passage of air in and out of the blood.” Fascinatingly, this homology extends to how fibroblasts evade capture by the body’s immune cells — via the proteins CD47 and PD-1.

Another inflammatory molecule that came into play was IL-6, a molecule whose predominant role in cancer is to promote tumor growth.

“When we looked at clinical tissue samples from lung fibrosis patients, we saw a huge increase in IL-6,” Wernig said. “IL-6 is known to be associated with chronic inflammatory disease, but it wasn’t clear how the molecule was contributing to the scarring process.”

By experimentally blocking CD47 and IL6 in a mouse model of idiopathic lung fibrosis, Wernig and team saw a massive reduction in lung scarring, as a result of increased immune clearance of fibroblasts. According to Wernig, this is a breakthrough for lung fibrosis patients, for whom clinical interventions beyond oxygen ventilators are extremely limited.

“This study presents hope for a new treatment option that could improve the condition of patients with lung fibrosis.” 

 

 

Sources: Nature Communications, Stanford Medicine.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 21, 2020
Immunology
CNS's immune cells - Microglia are involved in the exacerbation of MS
OCT 21, 2020
CNS's immune cells - Microglia are involved in the exacerbation of MS
Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where ...
OCT 21, 2020
Drug Discovery & Development
Experimental Vaccine Shows Promise in Halting Alzheimer's
OCT 21, 2020
Experimental Vaccine Shows Promise in Halting Alzheimer's
In a preclinical study, researchers from the Univerity of South Florida have found that a vaccine that targets neurotoxi ...
NOV 01, 2020
Cell & Molecular Biology
There's More to Neutrophil Function Than We Knew
NOV 01, 2020
There's More to Neutrophil Function Than We Knew
Neutrophils are an abundant type of white blood cell that circulate in the blood that can provide a general defense aga ...
NOV 10, 2020
Neuroscience
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
NOV 10, 2020
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain bar ...
DEC 31, 2020
Immunology
Arthritis Medication Resolves Previously Untreatable Skin Condition
DEC 31, 2020
Arthritis Medication Resolves Previously Untreatable Skin Condition
Bumpy, inflamed, ring-shaped lesions on the skin—granuloma annulare (GA) is a chronic, inflammatory skin condition ...
FEB 16, 2021
Immunology
Hugs From Immune Cells Heal Muscle
FEB 16, 2021
Hugs From Immune Cells Heal Muscle
Australian researchers have discovered a regenerative factor produced by immune cells that drives the repair and regener ...
Loading Comments...